Patient-Reported Outcomes after Chimeric Antigen Receptor T-Cell (CAR-T) Therapy in Patients with Relapsed/ Refractory Large B-Cell Lymphomas

被引：0
|
作者：
Balitsky, Amaris K. [1 ,2 ]
Pond, Gregory R. [2 ]
Fraser, Graeme [1 ,2 ]
Kouroukis, Tom [1 ,2 ]
Foley, Stephen Ronan [1 ,2 ]
机构：
[1] Hamilton Hlth Sci, Juravinski Canc Ctr, Hamilton, ON, Canada
[2] McMaster Univ, Dept Oncol, Hamilton, ON, Canada
来源：
BLOOD | 2022年 / 140卷
关键词：
D O I：
10.1182/blood-2022-165674
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：8036 / 8037
页数：2
相关论文
共 50 条
  • [41] Patient-Reported Outcomes with Chimeric Antigen Receptor T Cell Therapy: Challenges and Opportunities
    Chakraborty, Rajshekhar
    Sidana, Surbhi
    Shah, Gunjan L.
    Scordo, Michael
    Hamilton, Betty K.
    Majhail, Navneet S.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (05) : E155 - E162
  • [42] Five-Year Outcomes for Refractory B-Cell Lymphomas with CAR T-Cell Therapy
    Chong, Elise A.
    Ruella, Marco
    Schuster, Stephen J.
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (07): : 673 - 674
  • [43] Innovations in cancer immunotherapy: chimeric antigen receptor T-cell therapy (CAR-T)
    Brown, Kevin
    Seftel, Matthew D.
    Hay, Kevin A.
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2021, 193 (33) : E1300 - E1302
  • [44] CHIMERIC ANTIGEN RECEPTOR T CELL (CAR-T) THERAPY IN CHILDREN
    Desai, Devarshi
    Aragon, Camila Gonzalez
    Pabon, Camila
    Sendi, Prithvi Raj
    Meyer, Keith
    Totapally, Balagangadhar
    CRITICAL CARE MEDICINE, 2024, 52
  • [45] Patterns of Failure Following Chimeric Antigen Receptor T-cell (CAR-T) Therapy
    Figura, N. B.
    Jain, M. D.
    Sim, A. J.
    Chavez, J. C.
    Shah, B. D.
    Khimani, F.
    Lazaryan, A.
    Liu, H. D.
    Kim, S.
    Locke, F. L.
    Robinson, T. J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : S66 - S67
  • [46] Patient-Reported Neuropsychiatric Outcomes of Long-Term Survivors after Chimeric Antigen Receptor (CAR)-T Cell Therapy
    Bar, Merav
    Ruark, Julia
    Mullane, Erin
    Cleary, Nancy
    Cordeiro, Ana
    Bezerra, Evandro D.
    Voutsinas, Jenna M.
    Shaw, Bronwen E.
    Wu, Qian Vicky
    Flynn, Kathryn E.
    Lee, Stephanie J.
    Turtle, Cameron J.
    Maloney, David G.
    Fann, Jesse
    BLOOD, 2019, 134
  • [47] Outcomes of Chimeric Antigen Receptor (CAR) T-Cell Therapy in Patients with Large B-Cell Lymphoma (LBCL): A Single-Institution Experience
    Trando, Aaron
    Ter-Zakarian, Anna
    Yeung, Phillip
    Goodman, Aaron M.
    Hamdan, Ayad
    Hurley, Michael
    Jeong, Ah-Reum
    Tzachanis, Dimitrios
    CANCERS, 2023, 15 (18)
  • [48] Chimeric Antigen Receptor T-cell Therapy in Hematologic Malignancies and Patient-reported Outcomes: A Scoping Review
    Efficace, Fabio
    Cannella, Laura
    Sparano, Francesco
    Giesinger, Johannes M. M.
    Vignetti, Marco
    Baron, Frederic
    Bruera, Eduardo
    Luppi, Mario
    Platzbecker, Uwe
    HEMASPHERE, 2022, 6 (12): : E802
  • [49] Clinical Impact of Bridging Therapy Prior to Commercial Chimeric Antigen Receptor (CAR) T-Cell Therapies for Relapsed/Refractory Lymphomas
    Imber, Brandon S.
    Perales, Miguel-Angel
    Flynn, Jessica
    Ruiz, Josel D.
    Devlin, Sean
    Tomas, Ana Alarcon
    Hajj, Carla
    Batlevi, Connie Lee
    Dahi, Parastoo B.
    Lin, Richard J.
    Park, Jae H.
    Scordo, Michael
    Shah, Gunjan L.
    Giralt, Sergio A.
    Sauter, Craig S.
    Palomba, M. Lia
    Yahalom, Joachim
    BLOOD, 2020, 136
  • [50] Treatment Outcomes in Patients with R/R CNSL in the Era of Chimeric Antigen Receptor T-Cell (CAR-T) Therapy
    Yang, Fan
    Liu, Rui
    Fu, Zhonghua
    Guo, Yuelu
    Ma, Lixia
    Shi, Hui
    Deng, Biping
    Ke, Xiaoyan
    Hu, Kai
    BLOOD, 2024, 144 : 3079 - 3080
12345